对于绝经后骨质疏松症的他类药物的有效性:系统性审查和元分析
Pritam Biswas1, Sukumar Thorenoor Kumaraswamy2, Rob Hilgers3
1Medical Pharmacology, St. Matthews University School of Medicine, Georgeotown, CYM.
Cureus
|July 21, 2025
概括
在绝经后的骨质疏松症中,他类药物对骨矿物密度 (BMD) 的影响有限,脊椎或部BMD没有显著改善. 前臂 BMD 显示小幅增加,但证据不足以证明骨折风险降低.
科学领域:
- 骨代谢和内分泌学 骨代谢和内分泌学
- 药理学和治疗学 药理学和治疗学
- 老年医学 老年医学
背景情况:
- 骨质疏松症是绝经后妇女的主要健康问题,增加骨折风险.
- 用于心血管疾病的他类药物可能通过美酸盐途径影响骨健康.
- 对于他类药物在治疗骨质疏松症中的潜在作用,需要进行彻底的研究.
研究的目的:
- 系统地审查和元分析他类药物改善骨矿物质密度 (BMD) 的有效性.
- 评估他类药物对降低患有骨质疏松症的绝经后妇女骨折风险的影响.
- 为了评估骨转化标记物对他类药物治疗的反应.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析.
- 包括6个RCT,共1032名参与者.
- 主要结局的分析:骨质量变化 (腰椎,大腿部部,前臂),骨周转标志物和骨折发生率.
主要成果:
- 没有观察到腰椎或大腿部部BMD的显著改善.
- 根据有限的数据,在52周前臂BMD的统计上显著增加了1.1%,根据有限的数据.
- 骨周转标记的结果不一致,没有显著降低骨折风险.
结论:
- 类药物在绝经后的骨质疏松症中对骨质疏松症具有有限和特定的局部影响.
- 目前的证据不足以支持他类药物作为骨质疏松症的主要治疗方法.
- 对于同时患有心血管疾病的患者,可以考虑添加他类药物的使用;需要进一步的研究.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
878
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
878
01:26Atherosclerosis III: Management
36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36
01:29Bone Disorders
4.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
01:28Menopause
251
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
251
01:40Bone Remodeling
38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
01:31Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K